Advertisement

Topics

Elan Corporation, plc and Transition Therapeutics, Inc. Company Profile

19:50 EDT 18th March 2019 | BioPortfolio


News Articles [1187 Associated News Articles listed on BioPortfolio]

Transition Therapeutics licenses drug candidate from Eli Lilly

Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") fro...

Coming In Tuesday's "The Pink Sheet" DAILY - Royalty Pharma Makes A Move For Elan

Royalty Pharma’s $11 per-share bid for Elan is too low, according to Elan’s management and industry analysts.

Latest News From "The Pink Sheet" DAILY - Royalty Pharma Makes A Play For Elan

For Elan Investors, A Choice Between A Sure Thing Or A High-Risk Play

[Correspondence] From silos to sustainability: transition through a UHC lens

The transition to higher-income status is a positive step forward for countries, but this transition brings with it the prospect of declining external assistance, both in general and in particular for...

Abeona Therapeutics Announces CEO Transition

NEW YORK and CLEVELAND, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene thera...

Unum Therapeutics Announces Transition of Chief Financial Officer

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, t...

Why certain compounds have the potential to convert light into electrical energy

Transition-metal complexes - that is a cumbersome word for a class of molecules with important properties: An element from the group of transition metals sits in the centre. The outer electrons of the...

Autolus Therapeutics plc (AUTL) CEO Christian Itin on Transition Period from October 1 to December 31, 2018 - Earnings Call Transcript

PubMed Articles [1263 Associated PubMed Articles listed on BioPortfolio]

Potential immmunohistochemical markers to characterize epithelial-mesenchymal transition in pleomorphic adenoma.

The histogenesis process of pleomorphic adenoma (PA) of salivary gland continues to remain a controversial subject. In this neoplasm, transition occurs from an epithelial or myoepithelial cell to a st...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

Transition as a topic in psychiatry training throughout Europe: trainees' perspectives.

The majority of adolescents with mental health problems do not experience continuity of care when they reach the transition boundary of their child and adolescent mental health service. One of the obs...

Insulator-metal transition induced by electric voltage in a Ruthenate Mott insulator.

We report the observation of electric-voltage induced insulator-metal phase transition in a ruthenate Mott insulator Ca3(Ru0.9Ti0.1)2O7. We show that the electric field effect dominates and leads to a...

Clinical Trials [605 Associated Clinical Trials listed on BioPortfolio]

Open-Label Extension Study

The purpose of this study is to evaluate the long-term safety, tolerability and activity of Fampridine-SR in subjects with multiple sclerosis who have previously participated in either an ...

Transition of Diabetes Care From Pediatric to Adult Healthcare Providers.

A dedicated pre-transition class, as proposed in this study, could help facilitate a smooth transition between pediatric and adult diabetes care. The innovation in this study is that these...

Automated Youth-To-Adult Transition Planning Using Health Information ...

This study seeks to automate the process of youth to adult transition using an existing computerized decision support system in primary care. Subjects will complete the TRAQ readiness ques...

: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)

This study is a single center study of clinical and laboratory outcomes in patients ≥ 12 who transition from use of Orkambi to tez/iva. Clinical and laboratory measurements will be measu...

Evaluation of Web-based Transition Education to Enhance Transition Readiness

The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adul...

Companies [1615 Associated Companies listed on BioPortfolio]

Elan Corporation, plc and Transition Therapeutics, Inc.

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and real...

Elan plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing i...

Elan Corporation plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by bringing innovations in science...

Elan, plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing i...

More Information about "Elan Corporation, plc and Transition Therapeutics, Inc." on BioPortfolio

We have published hundreds of Elan Corporation, plc and Transition Therapeutics, Inc. news stories on BioPortfolio along with dozens of Elan Corporation, plc and Transition Therapeutics, Inc. Clinical Trials and PubMed Articles about Elan Corporation, plc and Transition Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elan Corporation, plc and Transition Therapeutics, Inc. Companies in our database. You can also find out about relevant Elan Corporation, plc and Transition Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record